Share this article According to GlobalData’s company profile on Forma Therapeutics, Cancer treatment biomarkers was a key innovation area identified from patents. Forma Therapeutics‘s grant
Share this article According to GlobalData’s company profile on Gilead Sciences, Peptide pharmacophores was a key innovation area identified from patents. Gilead Sciences‘s grant share
Share this article According to GlobalData’s company profile on UCB, Human telomerase RT biomarker was a key innovation area identified from patents. UCB‘s grant share
Share this article According to GlobalData’s company profile on Jubilant Pharmova, Graphene oxide composites was a key innovation area identified from patents. Jubilant Pharmova‘s grant
Share this article According to GlobalData’s company profile on Merck, Human telomerase RT biomarker was a key innovation area identified from patents. Merck‘s grant share
New research to be presented at this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27-30 April) shows that
New research to be presented at this year’s European Congress of Clinical Microbiology and Infectious Diseases in Barcelona, Spain (27-30 April) details the case of
PSYCHEDELIC DRUG DEVELOPMENT NEWS Drug Developer Skips the Trip Entirely, Unveils Deuterium-Assisted Psychotherapy Candidate (Apr 1) Initial reports describe the experience, though lacking psychedelics’ characteristic
AUXLY ANNOUNCES COMPLETION OF CONVERSION OF OVER $123 MILLION OF PRINCIPAL AND INTEREST UNDER IMPERIAL DEBENTURE Imperial Brands plc converts over $123 million in total
Ministers of Health from African countries with the highest burden of malaria committed today to accelerated action to end deaths from the disease.